- Home
- RVPH vs PPSI Comparison
RVPH vs PPSI Comparison
Compare RVPH & PPSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- PPSI
- Stock Information
- Founded
- RVPH 2006
- PPSI 2008
- Country
- RVPH United States
- PPSI United States
- Employees
- RVPH N/A
- PPSI N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- PPSI Electrical Products
- Sector
- RVPH Health Care
- PPSI Industrials
- Exchange
- RVPH Nasdaq
- PPSI Nasdaq
- Market Cap
- RVPH 32.8M
- PPSI 30.0M
- IPO Year
- RVPH N/A
- PPSI N/A
- Fundamental
- Price
- RVPH $0.37
- PPSI $2.67
- Analyst Decision
- RVPH Strong Buy
- PPSI Strong Buy
- Analyst Count
- RVPH 5
- PPSI 1
- Target Price
- RVPH $9.00
- PPSI $12.00
- AVG Volume (30 Days)
- RVPH 2.7M
- PPSI 37.5K
- Earning Date
- RVPH 08-13-2025
- PPSI 05-15-2025
- Dividend Yield
- RVPH N/A
- PPSI 56.18%
- EPS Growth
- RVPH N/A
- PPSI N/A
- EPS
- RVPH N/A
- PPSI 2.84
- Revenue
- RVPH N/A
- PPSI $26,304,000.00
- Revenue This Year
- RVPH N/A
- PPSI $24.01
- Revenue Next Year
- RVPH N/A
- PPSI $19.25
- P/E Ratio
- RVPH N/A
- PPSI $0.94
- Revenue Growth
- RVPH N/A
- PPSI 439.46
- 52 Week Low
- RVPH $0.30
- PPSI $2.25
- 52 Week High
- RVPH $4.28
- PPSI $7.00
- Technical
- Relative Strength Index (RSI)
- RVPH 30.92
- PPSI 46.95
- Support Level
- RVPH $0.35
- PPSI $2.64
- Resistance Level
- RVPH $0.83
- PPSI $2.78
- Average True Range (ATR)
- RVPH 0.06
- PPSI 0.10
- MACD
- RVPH -0.03
- PPSI 0.00
- Stochastic Oscillator
- RVPH 12.62
- PPSI 46.15
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About PPSI Pioneer Power Solutions Inc.
Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.